Showing results (1051-1060 of 1,069) with videos related to

Sort By:
Pageof 107
Contemporary Clinical Trials|September 2, 2022
Home-delivered meals for people with dementia: Which model delays nursing home placement? - Protocol for a feasibility pilotKali S Thomas, David M Dosa, Alison Fisher, et al.
Nature Communications|May 20, 2022
Engineered Cas12i2 is a versatile high-efficiency platform for therapeutic genome editingColin McGaw, Anthony J Garrity, Gabrielle Z Munoz, et al.
The Journal of Pharmacology and Experimental Therapeutics|May 13, 2006
Pharmacological characterization of the competitive GLUK5 receptor antagonist decahydroisoquinoline LY466195 in vitro and in vivoBrianne Weiss, Andrew Alt, Ann Marie Ogden, et al.
JAMA Pediatrics|November 7, 2022
Association of the COVID-19 Pandemic With Adolescent and Young Adult Eating Disorder Care VolumeSydney M Hartman-Munick, Jessica A Lin, Carly E Milliren, et al.
Bioorganic & Medicinal Chemistry Letters|November 22, 2005
Synthesis and structure-activity relationships of novel dipeptides and reduced dipeptides as ligands for melanocortin subtype-4 receptorQing Shi, Paul L Ornstein, Karin Briner, et al.
Journal of Medicinal Chemistry|September 20, 2002
Ethyl (3S,4aR,6S,8aR)-6-(4-ethoxycar- bonylimidazol-1-ylmethyl)decahydroiso-quinoline-3-carboxylic ester: a prodrug of a GluR5 kainate receptor antagonist active in two animal models of acute migraineSandra A Filla, Mark A Winter, Kirk W Johnson, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 27, 2019
Modulation of TARP γ8-Containing AMPA Receptors as a Novel Therapeutic Approach for Chronic PainKelly L Knopp, Rosa Maria A Simmons, Wenhong Guo, et al.
Bioorganic & Medicinal Chemistry Letters|October 15, 2013
GluK1 antagonists from 6-(carboxy)phenyl decahydroisoquinoline derivatives. SAR and evaluation of a prodrug strategy for oral efficacy in pain modelsJose A Martinez-Perez, Smriti Iyengar, Harlan E Shannon, et al.
Journal of Medicinal Chemistry|January 23, 2004
Synthesis and structure-activity relationships of novel arylpiperazines as potent and selective agonists of the melanocortin subtype-4 receptorTimothy I Richardson, Paul L Ornstein, Karin Briner, et al.
Nature Medicine|November 8, 2016
Forebrain-selective AMPA-receptor antagonism guided by TARP γ-8 as an antiepileptic mechanismAkihiko S Kato, Kevin D Burris, Kevin M Gardinier, et al.
Pageof 107